Business Wire Stock Sale/Buyback News

AG Mortgage Investment Trust, Inc. Announces Exercise of Underwriters’ Option

Thu, 9 Feb 2012 16:17:00 UT

NEW YORK--(BUSINESS WIRE)--AG Mortgage Investment Trust, Inc. (NYSE: MITT) (the “Company”) announced today the settlement of the sale of 750,000 shares of its common stock pursuant to the exercise in full of the underwriters’ option to purchase additional shares of the Company’s common stock at a price per share of $19.00. The underwriters’ option was granted in connection with the Company’s underwritten public offering of 5,000,000 shares of common stock which closed on January 24, 2012. With t

Philip Morris International Inc. (PMI) Reports 2011 Results; Provides 2012 Earnings Per Share Forecast

Thu, 9 Feb 2012 15:10:00 UT

NEW YORK--(BUSINESS WIRE)--Regulatory Disclosure: 2011 Full-Year Reported diluted earnings per share of $4.85, up by 23.7%, or by 18.9% excluding currency, versus $3.92 in 2010 Adjusted diluted earnings per share of $4.88, as detailed in the attached Schedule 16, up by 26.1%, or by 21.2% excluding currency, versus $3.87 in 2010 Cigarette shipment volume growth of 1.7% or 0.5%, excluding acquisitions Reported net revenues, excluding excise taxes, up by 14.3% to $31.1 billion, or by 9.2% excluding

Array BioPharma Announces Proposed Public Offering of Common Stock

Thu, 9 Feb 2012 14:00:00 UT

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) announced today the pricing of an underwritten public offering of 20,000,000 primary shares of its common stock at a public offering price of $2.60 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $52 million. The offering is expected to close on or about February 14, 2012, subject to customary closing condition

Kilroy Realty Corporation Prices Offering of Common Stock

Thu, 9 Feb 2012 13:45:00 UT

LOS ANGELES--(BUSINESS WIRE)--Kilroy Realty Corporation (NYSE: KRC) today announced that it has priced its public offering of 8,250,000 shares of its common stock at $42.00 per share. The offering is expected to close on Tuesday, February 14, 2012, subject to customary closing conditions. The underwriters for the public offering have been granted a 30-day option to purchase up to 1,237,500 additional shares of common stock to cover overallotments, if any. All of the shares are being sold by Kilr

IFS Continues Repurchasing Own Shares

Thu, 9 Feb 2012 07:41:00 UT

LULEÅ, Sweden--(BUSINESS WIRE)--Regulatory News: IFS (STO:IFSA)(STO:IFSB): In addition to previously communicated repurchases, the board of directors of Industrial and Financial Systems, IFS AB (“IFS”), (XSTO: IFS), has decided, on the basis of the authorization received from the annual general meeting, to further repurchase a maximum of 250,000 B shares in IFS, which corresponds to approximately 1.0 percent of all shares in the company, for a maximum aggregate consideration of SKr 25 million. T

MannKind Announces Exercise In Full of Over-Allotment Option and Completion of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock

Wed, 8 Feb 2012 22:00:00 UT

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today announced the completion of an underwritten public offering of 35,937,500 units, including 4,687,500 units sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters (with each unit consisting of one share of its common stock and a warrant to purchase 0.6 of a share of its common stock). All of the securities were offered by MannKind at a combined price to the public of $2.40 p

Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock

Wed, 8 Feb 2012 21:57:00 UT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that it has commenced an underwritten public offering of 5,250,000 shares of its Class A common stock.

Anacor Pharmaceuticals Announces the Sale of 3.25 Million Shares of Common Stock

Wed, 8 Feb 2012 21:20:00 UT

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (Nasdaq:ANAC), today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 487,500 shares of common stock to cover over-allotments, if any. The Company expects to use the net proceeds from the sale of the

Prudential Financial, Inc. Announces 2011 Results

Wed, 8 Feb 2012 21:07:00 UT

NEWARK, N.J.--(BUSINESS WIRE)--PRUDENTIAL FINANCIAL, INC. ANNOUNCES 2011 RESULTS

Alterra Capital Announces $0.14 Dividend and Increase in Share Repurchase Plan of $150 Million

Wed, 8 Feb 2012 21:05:00 UT

HAMILTON, Bermuda--(BUSINESS WIRE)--Alterra Capital Holdings Limited (NASDAQ: ALTE; BSX: ALTE.BH) (“Alterra”) announced today that Alterra’s Board of Directors declared a dividend of $0.14 per share. The dividend is payable on March 7, 2012, to shareholders of record as of February 22, 2012. In addition, on February 8, 2012, Alterra’s Board of Directors authorized an increase in the share repurchase plan of $150.0 million. Following this authorization, the amount available for share repurchases

Kilroy Realty Corporation Announces Commencement of Public Offering of Common Stock

Wed, 8 Feb 2012 21:01:00 UT

LOS ANGELES--(BUSINESS WIRE)--Kilroy Realty Corporation (NYSE:KRC) today announced that it has commenced a public offering of 7,000,000 shares of common stock. In addition, KRC expects to grant to the underwriters for the public offering a 30-day option to purchase up to 1,050,000 additional shares of common stock to cover overallotments, if any. Barclays Capital, J.P. Morgan, BofA Merrill Lynch, and Wells Fargo Securities, will act as joint book-running managers. KRC plans to contribute the net